Cytokinetics, Incorporated Free Cash Flow 1999–2025
Cytokinetics, Incorporated reported $-534.82M of free cash flow for fiscal 2025. That was 33.8% lower than fiscal 2024. Compared with fiscal 2020, the change was -25258.7%.
| Fiscal year | Free Cash Flow | Change (YoY) |
|---|---|---|
| FY 2025 | $-534.82M | -33.8% |
| FY 2024 | $-399.80M | +3.8% |
| FY 2023 | $-415.75M | -33.7% |
| FY 2022 | $-310.85M | -62.4% |
| FY 2021 | $-191.39M | -8975.1% |
| FY 2020 | $-2.11M | +97.7% |
| FY 2019 | $-93.53M | +8.4% |
| FY 2018 | $-102.10M | +2.4% |
| FY 2017 | $-104.64M | -395.7% |
| FY 2016 | $35.39M | +718.9% |
| FY 2015 | $4.32M | +109.4% |
| FY 2014 | $-45.95M | -456.3% |
| FY 2013 | $-8.26M | +75.4% |
| FY 2012 | $-33.56M | +27.1% |
| FY 2011 | $-46.04M | -1.6% |
| FY 2010 | $-45.32M | -676.2% |
| FY 2009 | $7.87M | — |
| FY 2008 | $0 | — |
| FY 2007 | $0 | — |
| FY 2006 | $0 | — |
| FY 2005 | $0 | — |
| FY 2004 | $0 | — |
| FY 2003 | $0 | — |
| FY 2002 | $0 | — |
| FY 2001 | $0 | — |
| FY 2000 | $0 | — |
| FY 1999 | $0 | — |
Source: Cytokinetics, Incorporated SEC filings — cash flow statement (10-K). Computed deterministically; refreshed nightly (last updated August 2, 2026). Open CYTK 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
Cytokinetics, Incorporated reported $-534.82M of free cash flow for fiscal 2025. That was 33.8% lower than fiscal 2024. Compared with fiscal 2020, the change was -25258.7%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for Cytokinetics, Incorporated
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeCytokinetics, Incorporated — frequently asked questions
What is Cytokinetics, Incorporated's free cash flow?
Cytokinetics, Incorporated (CYTK) reported free cash flow of $-534.82M for fiscal year 2025, per its SEC filings.
Where does this data come from?
Figures are computed from Cytokinetics, Incorporated's official SEC filings (cash flow statement (10-K)), refreshed nightly. Not investment advice.